260 Comments

Hello?! Ivermectin! A Merck created drug that no longer makes them money and looks to have better efficacy than whatever this is going to be. I find this disgusting.

Expand full comment

Damn, Molnupiravir is almost as effective as That Drug That Saved Uttar Pradesh from COVID19. Which costs about $30. Gosh, why doesn't FDA like a drug like that? Let me think. Aduhelm was $56,000, and they sure liked that. Even though the Aduhelm trial was stopped early "due to futility." And this new drug - Molnupiravir - it will cost $700. Uncle Sam has already bought it. So FDA will for sure like that one too. But that India-Saving-Drug? The $30 thing. What do they call it again? "The Drug That Will Never Be Approved." Because it is off-patent. And nobody makes money from it.

https://journals.lww.com/americantherapeutics/Fulltext/2021/08000/Ivermectin_for_Prevention_and_Treatment_of.7.aspx

But three cheers for Molnupiravir. Yay. Pharma (and their captured pals at FDA) stuffed approval of anything that looked like it might work (including vitamin D!) to retain "space" for the EUA for this monster. Can't have an EUA if there's already a treatment. Like, say, Ivermectin.

Expand full comment

I believe that Merck also makes another drug that is effective for treating and even preventing Covid-19. I believe it rhymes with "driver pectin."

Expand full comment

Alex, what on earth?! Uttar Pradesh had way better results with Ivermectin with millions in their “study.” Why are you not covering this?

Expand full comment

Wow, works almost as well as vitamin D.

Expand full comment

Mervermectin? To compete with Pfizermectin?

Expand full comment

Both Merck and Pfizer are developing ivermectin (IVM) clones. Simultaneously, hospitals are increasingly discouraging/forbidding IVM use, as ingestion of IVM is a disqualifier to study entry. Wonder why? I don't have a dollar amount on how much physicians earn from running studies, but it's not insubstantial. The doc who did this where I trained had a yacht parked in the Caribbean with it's own full-time staff. Docs at the local level knowingly doing this. This is sick. The Nazis would be so proud.

Expand full comment

Seen any studies on Ivermectin? My guess it is at least as good as this new Merck drug, but vastly less expensive.

Expand full comment

Should I list all the pharmaceutical companies I have worked for plus all those my husband has worked for? I am from NJ. All the big names there. Lived in NC as well. Again all the big guys there. They are most definitely all the same. Personnel rotates between many of them. Once upon a time, these multinationals did all of their own R&D. Now they buy into biotechs that have the promising drugs. Mostly me too drugs. Make a killing with an already approved drug now approved for another purpose. BTW, lab space in US the most corrupt and political landscape ever. Deep pockets win. So with cancer the bias is strongly slanted towards genetic origins. The metabolic folks hated and driven out. Actually ruined in some cases. Research is now not about looking where the science takes them, but about proving what deep pockets wants.

There are over 100 different chemo drugs. Think about that. Still using chemo all these years. That is NOT progress. Do you know the origins of chemo? Fascinating story. There is NO money in a cure. There is billions to be made approving drugs that barely move the needle. Do I sound cynical? I am just furious. Sick of the lies.

Expand full comment

Ivermectin and Molnupiravir seem to be completely unrelated drugs. Just a quick glance shows that Molnupiravir is essentially a nucleoside analog that gets incorporated during the virus transcription resulting in a mutation that inactivates the virus. It certainly sounds like it should work. It also sounds toxic.

Expand full comment

Promising…but this is just Merck’s replacement for Ivermectin. They just spent the summer shitting all over their own Nobel Prize-winning, inexpensive, widely available but off-patent Ivermectin so they could clear the path for their new, less effective, not yet safety tested but freshly patented and highly-profitable Molnupiravir.

Expand full comment

I could cry. Seriously. I might do it yet. Look, Alex. I know I don't have to give you a history lesson about Merck and the patent on Ivermectin, Merck's success with Ivermectin and its subsequent, unprovoked, national trashing of it once it started being touted as effective in stopping replication of COVID-19. And I know you are well aware of Merck's several, very expensive, failed attempts to produce a vaccine. This sidelined them. So they sought a therapeutic. Molnupiravir is a protease inhibitor which runs interference on viral replication. Ivermectin does the same. And I'd like to pit Ivermectin's track record against Molnupiravir's data any day of the week. The federal government has paid Merck $705 for each 5-day course of this new, red pill which should be good to go by the end of the year. Or until the campaign to threaten folks into being vaccinated, peters out, whichever comes first. 5 days of Ivermectin, by comparison costs about a buck. Monoclonal antibodies which also are an effective therapeutic were available a year ago. But nobody knew how to get 'em. Finally, they are here. I would not even want to venture a guess as to how many people died needlessly for want of a few tabs of Ivermectin and/or monoclonal antibody treatments. These therapeutics were held back for a reason and it doesn't take a rocket scientist to figure out why. I also remind you that the other "joke", hydroxychloroquine, is now known as a Zinc "booster" which aids in the T-cell immune response. I think now is the time for me to cry. Don't praise Merck. They would rather people die than miss an opportunity to horn in on the $billions in profits made possible by a global tragedy than give Ivermectin its due and lose out on the bonanza. Molnupiravir, this.

Expand full comment

Literally just like ivermectin. So we were denied a working therapy for 18 months so Merk can make million$

Expand full comment

You know what else they make? ivermectin 🤔

Expand full comment

Gotta know how they determined the numbers. Is that relative risk or absolute risk? Massive difference. Plus, they used the PCR test to determine these results. Yes, really. Also need to see how they screened test subjects. All of that can be seen here - https://clinicaltrials.gov/ct2/show/NCT04405739

Lest we forget, Merck is the company that gave us Vioxx, which was pulled from the market after many died from heart and strokes caused by Vioxx. There is also Gardasil with many court cases pending. Merck is a criminal enterprise just like Phizer.

Get a better return from sunshine, good diet, avoiding EMF's and toxins. All of that is much cheaper as well. https://secularheretic.substack.com/

Expand full comment

Or you could do a meta analysis on an existing drug having had 60+ peer reviewed studies including 30 RCT's which shows even greater efficacy than Merck's product and has the additional advantages of being much cheaper and has stellar long-term safety data. I think I'll take IVM over molnupiravir, thank you.

Expand full comment